Background	Background	NN	0
The	The	DT	0
p53	p53	NN	B-NP
tumor	tumor	NN	I-NP
suppressor	suppressor	NN	I-NP
gene	gene	NN	I-NP
is	is	VBZ	0
activated	activated	VBN	0
during	during	IN	0
several	several	JJ	0
cellular	cellular	JJ	B-NP
process	process	NN	I-NP
.	.	.	0
These	These	DT	0
include	include	JJ	0
DNA	DNA	NN	B-NP
damage	damage	NN	I-NP
caused	caused	VBN	0
by	by	IN	0
Ionizing	Ionizing	NNP	B-NP
Radiation	Radiation	NNP	I-NP
and	and	CC	0
genotoxic	genotoxic	JJ	B-NP
agent	agent	NN	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
,	,	,	0
by	by	IN	0
expression	expression	NN	0
of	of	IN	0
activated	activated	JJ	0
oncogene	oncogene	NN	B-NP
such	such	JJ	0
as	as	IN	0
ra	ra	NNP	B-NP
or	or	CC	0
myc	myc	NN	B-NP
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
,	,	,	0
or	or	CC	0
during	during	IN	0
progression	progression	NN	0
of	of	IN	0
primary	primary	JJ	B-NP
cell	cell	NN	I-NP
to	to	TO	0
senescence	senescence	VB	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
these	these	DT	0
diverse	diverse	JJ	B-NP
stimulus	stimulus	NN	I-NP
can	can	MD	0
initiate	initiate	VB	0
either	either	DT	0
growth	growth	NN	B-NP
arrest	arrest	NN	I-NP
or	or	CC	0
apoptosis	apoptosis	VBP	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
cellular	cellular	JJ	B-NP
context	context	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
sequence-specific	sequence-specific	NN	B-NP
dna	dna	NN	I-NP
p53	p53	NN	I-NP
posse	posse	NN	I-NP
binding	binding	JJ	0
activity	activity	NN	0
and	and	CC	0
functions	functions	NNS	0
in	in	IN	0
the	the	DT	0
cell	cell	NN	0
as	as	IN	0
a	a	DT	0
transcriptional	transcriptional	JJ	B-NP
regulator	regulator	NN	I-NP
.	.	.	0
Many	Many	JJ	0
regulated	regulated	VBN	B-NP
gene	gene	NN	I-NP
p53	p53	NN	I-NP
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
[	[	-LRB-	0
3	3	LS	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
majority	majority	NN	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
activation	activation	NNS	I-NP
cellular	cellular	JJ	I-NP
effect	effect	NN	I-NP
can	can	MD	0
be	be	VB	0
attributed	attributed	VBN	0
to	to	TO	0
the	the	DT	0
activation	activation	NN	B-NP
of	of	IN	0
these	these	DT	0
p53	p53	NN	B-NP
target	target	NN	I-NP
gene	gene	NN	I-NP
.	.	.	0
The	The	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
either	either	DT	0
DNA	DNA	NN	B-NP
damage	damage	NN	I-NP
or	or	CC	0
oncogene	oncogene	JJ	B-NP
expression	expression	NN	I-NP
occurs	occurs	VBZ	0
through	through	IN	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
stabilization	stabilization	NN	I-NP
.	.	.	0
In	In	IN	0
unstimulated	unstimulated	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
the	the	DT	0
mdm2	mdm2	JJ	B-NP
protein	protein	NN	I-NP
bind	bind	NN	I-NP
to	to	TO	0
the	the	DT	0
p53	p53	NN	B-NP
n-terminal	n-terminal	NN	I-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
and	and	CC	0
targets	targets	NNS	0
it	it	PRP	0
for	for	IN	0
ubiquitin-dependent	ubiquitin-dependent	JJ	B-NP
degradation	degradation	NN	I-NP
[	[	-LRB-	0
6	6	CD	0
,	,	,	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
requires	requires	VBZ	0
disruption	disruption	NN	0
of	of	IN	0
the	the	DT	0
mdm2-p53	mdm2-p53	JJ	B-NP
interaction	interaction	NN	I-NP
to	to	TO	0
allow	allow	VB	0
p53	p53	NN	B-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
the	the	DT	0
cell.	cell.	CD	0
2	2	CD	0
distinct	distinct	JJ	0
mechanisms	mechanisms	NNS	0
for	for	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
have	have	VBP	0
so	so	RB	0
far	far	RB	0
been	been	VBN	0
elucidated	elucidated	NN	0
.	.	.	0
The	The	DT	0
expression	expression	NN	0
of	of	IN	0
oncogenes	oncogenes	JJ	0
such	such	JJ	0
as	as	IN	0
ra	ra	NNP	B-NP
in	in	IN	0
untransformed	untransformed	JJ	B-NP
cell	cell	NN	I-NP
stimulates	stimulates	VBP	0
p14	p14	NNP	B-NP
arfgene	arfgene	NN	I-NP
transcription	transcription	VBN	I-NP
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
p14	p14	NN	B-NP
arfbind	arfbind	NN	I-NP
to	to	TO	0
and	and	CC	0
sequesters	sequesters	CD	0
mdm2	mdm2	CD	B-NP
,	,	,	0
allowing	allowing	VBG	0
free	free	JJ	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
to	to	TO	0
accumulate	accumulate	VB	0
in	in	IN	0
the	the	DT	0
cells	cells	NNS	0
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
is	is	VBZ	0
also	also	RB	0
brought	brought	VBN	0
about	about	RB	0
by	by	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
p53-mdm2	p53-mdm2	CD	B-NP
interaction	interaction	NN	I-NP
.	.	.	0
The	The	DT	0
product	product	NN	0
of	of	IN	0
the	the	DT	0
Ataxia	Ataxia	NNP	B-NP
Telangiectasia	Telangiectasia	NNP	I-NP
gene	gene	NN	I-NP
,	,	,	0
the	the	DT	0
ATM	ATM	NNP	B-NP
protein	protein	NN	I-NP
kinasa	kinasa	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
directly	directly	RB	0
serine	serine	CD	B-NP
phosphorylate	phosphorylate	NN	I-NP
15	15	CD	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ionizing	Ionizing	NNP	B-NP
Radiation	Radiation	NNP	I-NP
[	[	-LRB-	0
10	10	CD	0
,	,	,	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
atm	atm	NN	B-NP
phosphorylate	phosphorylate	NN	I-NP
and	and	CC	0
activates	activates	FW	0
chk2	chk2	NN	B-NP
kinase	kinase	NN	I-NP
[	[	-LRB-	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
Activated	Activated	NNP	B-NP
chk2	chk2	NNP	I-NP
can	can	MD	0
then	then	RB	0
directly	directly	RB	0
phosphorylate	phosphorylate	CD	B-NP
serine	serine	CD	I-NP
20	20	CD	0
of	of	IN	0
p53	p53	NN	B-NP
[	[	-LRB-	0
13	13	CD	0
,	,	,	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
ATM	ATM	NNP	B-NP
therefore	therefore	RB	0
controls	controls	VBZ	0
the	the	DT	0
serine	serine	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
15	15	CD	0
and	and	CC	0
20	20	CD	0
of	of	IN	0
p53	p53	NN	B-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
increases	increases	VBZ	0
the	the	DT	0
serine	serine	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
33	33	CD	0
and	and	CC	0
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
through	through	IN	0
an	an	DT	0
ATM-independent	ATM-independent	JJ	B-NP
mechanism	mechanism	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
,	,	,	0
16	16	CD	0
,	,	,	0
17	17	CD	0
,	,	,	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
DNA	DNA	NN	B-NP
damage-induced	damage-induced	JJ	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
block	block	VB	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
mdm2	mdm2	CD	B-NP
to	to	TO	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
n-terminal	n-terminal	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
phosphorylation	phosphorylation	VBN	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
or	or	CC	0
expression	expression	NN	0
of	of	IN	0
p14Arf	p14Arf	NNP	0
prevents	prevents	VBZ	0
mdm2	mdm2	CD	B-NP
binding	binding	NNS	0
and	and	CC	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
then	then	RB	0
accumulates	accumulates	VBN	0
in	in	IN	0
the	the	DT	0
cell	cell	NN	0
.	.	.	0
Although	Although	IN	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
stabilization	stabilization	NN	I-NP
is	is	VBZ	0
the	the	DT	0
initial	initial	JJ	0
step	step	NN	0
in	in	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
,	,	,	0
subsequent	subsequent	JJ	0
steps	steps	NNS	0
,	,	,	0
including	including	VBG	B-NP
activation	activation	NN	I-NP
of	of	IN	0
p53	p53	NN	0
's	's	POS	0
DNA	DNA	NN	B-NP
binding	binding	JJ	0
activity	activity	NN	0
and	and	CC	0
changes	changes	NNS	0
in	in	IN	0
p53	p53	NN	0
's	's	POS	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
are	are	VBP	0
also	also	RB	0
involved	involved	VBN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
p53	p53	NN	0
's	's	POS	0
DNA	DNA	NN	B-NP
binding	binding	JJ	0
activity	activity	NN	0
is	is	VBZ	0
increased	increased	VBN	0
by	by	IN	0
the	the	DT	0
DNA	DNA	NN	B-NP
damage-induced	damage-induced	JJ	0
p53	p53	NN	B-NP
c-terminal	c-terminal	NN	I-NP
acetylation	acetylation	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
,	,	,	0
19	19	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
this	this	DT	0
acetylation	acetylation	NN	B-NP
requires	requires	VBZ	0
the	the	DT	0
prior	prior	JJ	0
p53	p53	NN	B-NP
n-terminal	n-terminal	NN	I-NP
phosphorylation	phosphorylation	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
phosphorylation	phosphorylation	VBG	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
n-terminal	n-terminal	NN	I-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
may	may	MD	0
be	be	VB	0
required	required	VBN	0
to	to	TO	0
stimulate	stimulate	VB	0
p53	p53	NN	B-NP
target	target	NN	I-NP
gene	gene	NN	I-NP
transcriptional	transcriptional	JJ	I-NP
activation	activation	NN	I-NP
.	.	.	0
multiple	multiple	JJ	B-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
have	have	VBP	0
been	been	VBN	0
detected	detected	VBN	0
in	in	IN	0
the	the	DT	0
p53	p53	NN	B-NP
n-terminal	n-terminal	NN	I-NP
,	,	,	0
including	including	VBG	B-NP
serine	serine	NN	I-NP
6	6	CD	0
,	,	,	0
9	9	CD	0
,	,	,	0
15	15	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
33	33	CD	0
,	,	,	0
37	37	CD	0
and	and	CC	0
46	46	CD	0
[	[	-LRB-	0
10	10	CD	0
,	,	,	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
21	21	CD	0
,	,	,	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
While	While	IN	0
serine	serine	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
15	15	CD	0
and	and	CC	0
20	20	CD	0
of	of	IN	0
p53	p53	NN	B-NP
are	are	VBP	0
clearly	clearly	RB	0
dependent	dependent	JJ	0
on	on	IN	0
the	the	DT	0
ATM	ATM	NNP	B-NP
and	and	CC	0
chk2	chk2	CD	B-NP
protein	protein	NN	I-NP
kinas	kinas	NNP	I-NP
[	[	-LRB-	0
10	10	CD	0
,	,	,	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
]	]	-RRB-	0
,	,	,	0
the	the	DT	0
phosphorylation	phosphorylation	NN	B-NP
kinases	kinases	JJ	I-NP
responsible	responsible	JJ	I-NP
of	of	IN	0
the	the	DT	0
remaining	remaining	JJ	0
serine	serine	JJ	B-NP
residue	residue	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
is	is	VBZ	0
not	not	RB	0
clear	clear	JJ	0
.	.	.	0
The	The	DT	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
or	or	CC	0
oncogenes	oncogenes	JJ	0
such	such	JJ	0
as	as	IN	0
ras	ras	JJ	B-NP
result	result	NN	I-NP
in	in	IN	0
either	either	DT	0
growth	growth	NN	B-NP
arrest	arrest	NN	I-NP
or	or	CC	0
apoptosi	apoptosi	NN	B-NP
of	of	IN	0
the	the	DT	0
affected	affected	JJ	0
cell	cell	NN	0
.	.	.	0
In	In	IN	0
this	this	DT	0
study	study	NN	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
examined	examined	VBN	0
how	how	WRB	0
Glycogen	Glycogen	NNP	0
Synthase	Synthase	NNP	0
Kinase	Kinase	NNP	0
3β	3β	NNP	0
(	(	-LRB-	0
GSK3β	GSK3β	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
protein	protein	NN	B-NP
kinase	kinase	VBZ	0
involved	involved	VBN	0
in	in	IN	0
tumorigenesi	tumorigenesi	NN	B-NP
,	,	,	0
differentiation	differentiation	NN	B-NP
and	and	CC	0
apoptosi	apoptosi	NN	B-NP
,	,	,	0
regulates	regulates	VBZ	0
the	the	DT	0
function	function	NN	0
of	of	IN	0
p53	p53	NN	B-NP
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
phosphorylates	phosphorylates	VBD	0
several	several	JJ	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
,	,	,	0
including	including	VBG	0
NFATc	NFATc	JJ	0
and	and	CC	0
HSF1	HSF1	NNP	B-NP
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
25	25	CD	0
,	,	,	0
26	26	CD	0
,	,	,	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
constitutively	constitutively	JJ	0
active	active	JJ	0
in	in	IN	0
resting	resting	JJ	0
cells	cells	NNS	0
but	but	CC	0
is	is	VBZ	0
inhibited	inhibited	VBN	0
when	when	WRB	0
cells	cells	NNS	0
are	are	VBP	0
exposed	exposed	VBN	0
to	to	TO	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
GSK3	GSK3	NNP	B-NP
inhibition	inhibition	NN	I-NP
occurs	occurs	VBZ	0
when	when	WRB	0
the	the	DT	0
p110-PI	p110-PI	NNP	0
3-kinase	3-kinase	NNP	0
/	/	NNP	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
B	B	NNP	I-NP
(	(	-LRB-	0
PKB	PKB	NNP	B-NP
)	)	-RRB-	0
pathway	pathway	NN	0
is	is	VBZ	0
activated	activated	VBN	0
by	by	IN	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
24	24	CD	0
,	,	,	0
25	25	CD	0
,	,	,	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
Activated	Activated	NNP	B-NP
PKB	PKB	NNP	I-NP
then	then	RB	0
gsk3β	gsk3β	NN	B-NP
phosphorylate	phosphorylate	NN	I-NP
,	,	,	0
inhibiting	inhibiting	VBG	B-NP
GSK3	GSK3	NN	I-NP
kinase	kinase	NN	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
activation	activation	NN	B-NP
of	of	IN	0
the	the	DT	0
p110-PI	p110-PI	NNP	0
3-kinase	3-kinase	NNP	0
/	/	NNP	0
PKB	PKB	NNP	0
pathway	pathway	NN	0
,	,	,	0
and	and	CC	0
inhibition	inhibition	NN	0
of	of	IN	0
GSK3	GSK3	NNP	B-NP
,	,	,	0
delivers	delivers	VBZ	0
a	a	DT	0
strong	strong	JJ	0
anti-apoptotic	anti-apoptotic	JJ	B-NP
signal	signal	NN	I-NP
to	to	TO	0
the	the	DT	0
cell	cell	NN	0
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
24	24	CD	0
,	,	,	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Given	Given	VBN	0
the	the	DT	0
well	well	RB	0
characterized	characterized	VBN	0
role	role	NN	0
of	of	IN	0
p53	p53	NN	B-NP
in	in	IN	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
3	3	LS	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
if	if	IN	0
GSK3p	GSK3p	CD	0
participates	participates	NN	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
GSK3	GSK3	NNP	B-NP
phosphorylates	phosphorylates	VBD	0
the	the	DT	0
consensus	consensus	NN	B-NP
sequence	sequence	NN	I-NP
Ser-X-X-X-Ser	Ser-X-X-X-Ser	NN	I-NP
(	(	-LRB-	I-NP
P	P	NN	I-NP
)	)	-RRB-	I-NP
,	,	,	0
where	where	WRB	0
the	the	DT	0
serine	serine	JJ	B-NP
residue	residue	NN	I-NP
c-terminal	c-terminal	NN	I-NP
is	is	VBZ	0
already	already	RB	0
phosphorylated	phosphorylated	JJ	0
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
GSK3	GSK3	RB	0
only	only	RB	0
phosphorylates	phosphorylates	JJ	B-NP
target	target	NN	I-NP
protein	protein	NN	I-NP
which	which	WDT	0
have	have	VBP	0
already	already	RB	0
been	been	VBN	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
a	a	DT	0
separate	separate	JJ	0
,	,	,	0
priming	priming	CD	B-NP
kinase.	kinase.	CD	I-NP
p53	p53	NN	B-NP
contains	contains	VBZ	0
5	5	CD	0
potential	potential	JJ	B-NP
gsk3	gsk3	NN	I-NP
phosphorylation	phosphorylation	CD	I-NP
site	site	NN	I-NP
,	,	,	0
3	3	CD	0
in	in	IN	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
and	and	CC	0
2	2	CD	0
in	in	IN	0
the	the	DT	0
regulatory	regulatory	JJ	B-NP
domain	domain	NN	I-NP
c-terminal	c-terminal	NN	I-NP
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
GSK3β	GSK3β	NNP	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
GSK3α	GSK3α	CD	B-NP
,	,	,	0
can	can	MD	0
phosphorylate	phosphorylate	VB	0
serine	serine	CD	B-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
when	when	WRB	0
serine	serine	JJ	0
37	37	CD	0
is	is	VBZ	0
already	already	RB	0
phosphorylated	phosphorylated	VBN	0
.	.	.	0
Further	Further	RB	0
,	,	,	0
GSK3β	GSK3β	NNP	B-NP
can	can	MD	0
increase	increase	VB	0
p53	p53	NN	0
's	's	POS	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
and	and	CC	0
this	this	DT	0
activation	activation	NN	B-NP
is	is	VBZ	0
lost	lost	VBN	0
when	when	WRB	0
serine	serine	JJ	0
33	33	CD	0
is	is	VBZ	0
mutated	mutated	VBN	0
to	to	TO	0
alanine	alanine	VB	0
.	.	.	0
Results	Results	NNS	0
The	The	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
contains	contains	VBZ	0
several	several	JJ	0
serine	serine	JJ	B-NP
residue	residue	NN	I-NP
which	which	WDT	0
are	are	VBP	0
located	located	VBN	0
within	within	IN	0
potential	potential	JJ	B-NP
gsk3	gsk3	NN	I-NP
phosphorylation	phosphorylation	CD	I-NP
site	site	NN	I-NP
.	.	.	0
protein	protein	NN	B-NP
kinas	kinas	NNP	I-NP
which	which	WDT	0
can	can	MD	0
phosphorylate	phosphorylate	VB	0
p53	p53	NN	B-NP
within	within	IN	0
these	these	DT	0
predicted	predicted	VBD	B-NP
gsk3	gsk3	NN	I-NP
site	site	NN	I-NP
include	include	VBP	0
MAP	MAP	JJ	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
A	A	NNP	0
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
C	C	NNP	I-NP
,	,	,	0
Casein	Casein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
II	II	NNP	I-NP
,	,	,	0
Jun	Jun	NNP	0
kinasa	kinasa	NN	B-NP
(	(	-LRB-	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
DNA-dependent	DNA-dependent	NNP	B-NP
Protein	Protein	NNP	I-NP
Kinase	Kinase	NNP	I-NP
(	(	-LRB-	0
DNA-PK	DNA-PK	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
30	30	CD	0
,	,	,	0
31	31	CD	0
,	,	,	0
32	32	CD	0
,	,	,	0
33	33	CD	0
,	,	,	0
34	34	CD	0
,	,	,	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
kinas	kinas	NNP	B-NP
were	were	VBD	0
examined	examined	VBN	0
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
they	they	PRP	0
can	can	MD	0
act	act	VB	0
as	as	IN	0
the	the	DT	0
priming	priming	JJ	0
kinase	kinase	NN	B-NP
for	for	IN	0
either	either	RB	0
of	of	IN	0
the	the	DT	0
2	2	CD	0
gsk3	gsk3	NN	B-NP
isoform	isoform	NN	I-NP
,	,	,	0
GSK3α	GSK3α	NNP	B-NP
and	and	CC	0
GSK3β	GSK3β	NNP	B-NP
.	.	.	0
The	The	DT	0
general	general	JJ	0
protocol	protocol	NN	0
was	was	VBD	0
to	to	TO	0
incubate	incubate	VB	0
purified	purified	JJ	0
priming	priming	JJ	0
kinas	kinas	NNP	B-NP
with	with	IN	0
p53-GST	p53-GST	CD	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
and	and	CC	0
ATP	ATP	NNP	B-NP
for	for	IN	0
5	5	CD	0
h	h	NN	0
,	,	,	0
then	then	RB	0
heat	heat	VB	0
inactivate	inactivate	VBN	0
the	the	DT	0
priming	priming	JJ	0
kinase	kinase	NN	B-NP
.	.	.	0
preliminary	preliminary	JJ	B-NP
experiment	experiment	NN	I-NP
indicated	indicated	VBD	0
that	that	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
tested	tested	JJ	0
kinas	kinas	NNP	B-NP
was	was	VBD	0
able	able	JJ	0
to	to	TO	0
phosphorylate	phosphorylate	CD	B-NP
p53-GST	p53-GST	CD	I-NP
under	under	IN	0
the	the	DT	0
experimental	experimental	JJ	B-NP
condition	condition	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
prephosphorylated	prephosphorylated	JJ	B-NP
p53-gst	p53-gst	NN	I-NP
aliquot	aliquot	NN	I-NP
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
with	with	IN	0
or	or	CC	0
without	without	IN	0
recombinant	recombinant	JJ	0
GSK3α	GSK3α	NN	B-NP
or	or	CC	0
GSK3β	GSK3β	NNP	B-NP
and	and	CC	0
32P-ATP	32P-ATP	CD	0
to	to	TO	0
measure	measure	VB	0
p53	p53	CD	B-NP
phosphorylation.	phosphorylation.	CD	I-NP
p53-GST	p53-GST	CD	B-NP
preincubated	preincubated	NN	0
in	in	IN	0
buffer	buffer	NN	B-NP
alone	alone	RB	0
,	,	,	0
and	and	CC	0
then	then	RB	0
exposed	exposed	VBN	0
to	to	TO	0
the	the	DT	0
heat	heat	NN	B-NP
inactivation	inactivation	NN	I-NP
protocol	protocol	NN	I-NP
was	was	VBD	0
not	not	RB	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
either	either	DT	0
GSK3α	GSK3α	NNP	B-NP
or	or	CC	0
GSK3β	GSK3β	NNP	B-NP
(	(	-LRB-	0
fig	fig	CD	0
1	1	CD	0
,	,	,	0
Control	Control	NNP	0
)	)	-RRB-	0
.	.	.	0
gsk3α	gsk3α	NN	B-NP
autophosphorylation	autophosphorylation	NN	I-NP
and	and	CC	0
GSK3β	GSK3β	NNP	B-NP
can	can	MD	0
be	be	VB	0
seen	seen	VBN	0
(	(	-LRB-	0
figure	figure	NN	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Unphosphorylated	Unphosphorylated	NNP	0
p53-GST	p53-GST	NNP	B-NP
is	is	VBZ	0
therefore	therefore	RB	0
not	not	RB	0
a	a	DT	0
substrate	substrate	NN	0
for	for	IN	0
GSK3α	GSK3α	NNP	B-NP
or	or	CC	0
GSK3β	GSK3β	CD	B-NP
in	in	IN	0
vitro.	vitro.	NNP	B-NP
p53-GST	p53-GST	NNP	B-NP
was	was	VBD	0
then	then	RB	0
prephosphorylated	prephosphorylated	VBN	0
with	with	IN	0
MAP	MAP	NNP	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
S6	S6	CD	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
A	A	NNP	0
,	,	,	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
and	and	CC	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
C	C	NNP	I-NP
(	(	-LRB-	0
fig	fig	CD	0
1	1	CD	0
)	)	-RRB-	0
or	or	CC	0
Casein	Casein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
II	II	NNP	I-NP
and	and	CC	0
JNK1	JNK1	NNP	B-NP
/	/	NNP	0
JNK2	JNK2	NNP	B-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Following	Following	VBG	0
incubation	incubation	NN	0
in	in	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
primary	primary	JJ	B-NP
kinas	kinas	NNP	I-NP
,	,	,	0
the	the	DT	0
prephosphorylated	prephosphorylated	JJ	B-NP
p53-GST	p53-GST	NN	I-NP
was	was	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
with	with	IN	0
32P-ATP	32P-ATP	NNP	0
and	and	CC	0
either	either	DT	0
GSK3α	GSK3α	NNP	B-NP
or	or	CC	0
GSK3β	GSK3β	NNP	B-NP
.	.	.	0
p53-gst	p53-gst	NN	B-NP
prephosphorylation	prephosphorylation	NN	I-NP
by	by	IN	0
MAP	MAP	NNP	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
S6	S6	CD	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
A	A	NNP	0
or	or	CC	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
C	C	NNP	I-NP
(	(	-LRB-	0
fig	fig	CD	0
1	1	CD	0
)	)	-RRB-	0
or	or	CC	0
Casein	Casein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
II	II	NNP	I-NP
or	or	CC	0
JNK1	JNK1	NNP	B-NP
or	or	CC	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
2	2	CD	0
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
failed	failed	VBD	0
to	to	TO	0
create	create	VB	0
a	a	DT	0
phosphorylation	phosphorylation	JJ	B-NP
site	site	NN	I-NP
for	for	IN	0
either	either	DT	0
GSK3α	GSK3α	NNP	B-NP
or	or	CC	0
GSK3β	GSK3β	NNP	B-NP
.	.	.	0
However	However	RB	0
,	,	,	0
prephosphorylation	prephosphorylation	VBG	0
of	of	IN	0
p53-GST	p53-GST	CD	B-NP
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
resulted	resulted	VBD	0
in	in	IN	0
strong	strong	JJ	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
(	(	-LRB-	0
fig	fig	CD	0
1	1	CD	0
)	)	-RRB-	0
but	but	CC	0
not	not	RB	0
GSK3α	GSK3α	CD	B-NP
.	.	.	0
GST	GST	NNP	B-NP
protein	protein	NN	I-NP
alone	alone	RB	0
incubated	incubated	VBN	0
with	with	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
was	was	VBD	0
not	not	RB	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Since	Since	IN	0
there	there	EX	0
was	was	VBD	0
no	no	DT	0
significant	significant	JJ	0
p53-gst	p53-gst	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
GSK3α	GSK3α	NNP	B-NP
(	(	-LRB-	0
fig	fig	CD	0
1	1	CD	0
)	)	-RRB-	0
,	,	,	0
this	this	DT	0
indicates	indicates	VBZ	0
that	that	DT	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
in	in	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
creates	creates	VBZ	0
a	a	DT	0
site	site	NN	0
for	for	IN	0
GSK3β	GSK3β	CD	B-NP
to	to	TO	0
phosphorylate	phosphorylate	VB	0
p53	p53	NN	B-NP
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
we	we	PRP	0
set	set	VBD	0
out	out	RP	0
to	to	TO	0
identify	identify	VB	0
the	the	DT	0
exact	exact	JJ	0
amino-acid	amino-acid	NN	B-NP
within	within	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
which	which	WDT	0
were	were	VBD	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
GSK3β.	GSK3β.	CD	B-NP
p53	p53	NN	B-NP
is	is	VBZ	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
at	at	IN	0
serine	serine	NN	B-NP
15	15	CD	0
and	and	CC	0
37	37	CD	0
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
Of	Of	IN	0
these	these	DT	0
2	2	CD	0
sites	sites	NNS	0
,	,	,	0
the	the	DT	0
sequence	sequence	NN	0
around	around	IN	0
serine	serine	CD	B-NP
37	37	CD	0
contains	contains	VBZ	0
a	a	DT	0
predicted	predicted	VBD	B-NP
GSK3	GSK3	CD	I-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
at	at	IN	0
serine	serine	CD	B-NP
33	33	CD	0
(	(	-LRB-	0
figure	figure	NN	0
2	2	CD	0
,	,	,	0
underlined	underlined	CD	0
)	)	-RRB-	0
.	.	.	0
Serine	Serine	NNP	B-NP
33	33	CD	0
and	and	CC	0
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
were	were	VBD	0
individually	individually	RB	0
mutated	mutated	VBN	0
to	to	TO	0
alanine	alanine	VB	0
,	,	,	0
and	and	CC	0
p53-gst	p53-gst	NN	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
containing	containing	VBG	0
these	these	DT	0
mutations	mutations	NN	0
prepared	prepared	VBN	0
.	.	.	0
The	The	DT	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
ability	ability	NN	I-NP
to	to	TO	0
create	create	VB	0
a	a	DT	0
GSK3β	GSK3β	JJ	B-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
on	on	IN	0
these	these	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
was	was	VBD	0
then	then	RB	0
examined	examined	VBN	0
.	.	.	0
In	In	IN	0
the	the	DT	0
p53	p53	NN	B-NP
absence	absence	NN	I-NP
,	,	,	0
no	no	DT	0
phosphorylation	phosphorylation	NN	B-NP
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
was	was	VBD	0
detected	detected	VBN	0
(	(	-LRB-	0
fig	fig	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
Unphosphorylated	Unphosphorylated	NNP	0
p53-GST	p53-GST	NNP	B-NP
was	was	VBD	0
not	not	RB	0
a	a	DT	0
substrate	substrate	NN	0
for	for	IN	0
GSK3β	GSK3β	NNP	B-NP
,	,	,	0
whereas	whereas	IN	0
p53-GST	p53-GST	CD	B-NP
prephosphorylated	prephosphorylated	NN	0
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
was	was	VBD	0
(	(	-LRB-	0
fig	fig	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
Mutation	Mutation	NN	0
of	of	IN	0
serine	serine	CD	B-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
to	to	TO	0
alanine	alanine	VB	0
(	(	-LRB-	0
S33A	S33A	NNP	0
)	)	-RRB-	0
blocked	blocked	VBD	0
the	the	DT	0
gsk3β	gsk3β	NN	B-NP
ability	ability	NN	I-NP
to	to	TO	0
phosphorylate	phosphorylate	VB	0
p53	p53	NN	B-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
serine	serine	CD	B-NP
33	33	CD	0
is	is	VBZ	0
the	the	DT	0
likely	likely	JJ	0
target	target	NN	0
for	for	IN	0
GSK3β	GSK3β	NNP	B-NP
(	(	-LRB-	0
fig	fig	CD	0
2	2	CD	0
,	,	,	0
33	33	CD	0
)	)	-RRB-	0
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
mutation	mutation	NN	0
of	of	IN	0
serine	serine	CD	B-NP
37	37	CD	0
,	,	,	0
which	which	WDT	0
abolishes	abolishes	VBZ	0
the	the	DT	0
phosphorylation	phosphorylation	JJ	B-NP
site	site	NN	I-NP
dependent	dependent	JJ	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
blocks	blocks	VBZ	0
phosphorylation	phosphorylation	VBN	0
of	of	IN	0
p53	p53	NN	B-NP
by	by	IN	0
GSK3β	GSK3β	CD	B-NP
.	.	.	0
This	This	DT	0
indicates	indicates	VBZ	0
that	that	DT	0
p53	p53	NN	B-NP
must	must	MD	0
be	be	VB	0
phosphorylated	phosphorylated	VBN	0
on	on	IN	0
serine	serine	CD	B-NP
37	37	CD	0
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
before	before	IN	0
it	it	PRP	0
can	can	MD	0
be	be	VB	0
phosphorylated	phosphorylated	VBN	0
at	at	IN	0
serine	serine	CD	B-NP
33	33	CD	0
by	by	IN	0
GSK3β	GSK3β	CD	B-NP
.	.	.	0
To	To	TO	0
examine	examine	VB	0
the	the	DT	0
in	in	IN	0
vivo	vivo	JJ	B-NP
function	function	NN	I-NP
of	of	IN	0
these	these	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
phosphorylation	phosphorylation	NN	I-NP
,	,	,	0
wtp53	wtp53	NNP	B-NP
and	and	CC	0
p53	p53	NN	B-NP
with	with	IN	0
the	the	DT	0
S33A	S33A	NNP	0
and	and	CC	0
S37A	S37A	CD	0
mutations	mutations	NNS	0
were	were	VBD	0
sub-cloned	sub-cloned	JJ	B-NP
into	into	IN	0
the	the	DT	0
expression	expression	NN	B-NP
vector	vector	NN	I-NP
pcDNA3.1	pcDNA3.1	NN	I-NP
.	.	.	0
These	These	DT	0
were	were	VBD	0
then	then	RB	0
expressed	expressed	VBN	0
in	in	IN	0
the	the	DT	0
human	human	JJ	0
osteosarcoma	osteosarcoma	JJ	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
SAOS-2	SAOS-2	NN	I-NP
,	,	,	0
which	which	WDT	0
does	does	VBZ	0
not	not	RB	0
express	express	VB	0
endogenous	endogenous	JJ	B-NP
p53	p53	NN	I-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
First	First	NNP	0
,	,	,	0
we	we	PRP	0
analyzed	analyzed	VBD	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
expression	expression	NN	0
of	of	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
following	following	VBG	0
transient	transient	JJ	0
expression	expression	NN	0
in	in	IN	0
saos-2	saos-2	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
In	In	IN	0
fig	fig	CD	0
3A	3A	CD	0
,	,	,	0
approx	approx	JJ	0
equal	equal	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
wtp53	wtp53	NNP	B-NP
,	,	,	0
p53S33A	p53S33A	NNP	0
and	and	CC	0
p53S37A	p53S37A	NNP	0
were	were	VBD	0
detected	detected	VBN	0
by	by	IN	0
western	western	JJ	0
blot	blot	NN	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
they	they	PRP	0
were	were	VBD	0
expressed	expressed	VBN	0
at	at	IN	0
similar	similar	JJ	0
levels	levels	NNS	0
.	.	.	0
In	In	IN	0
fig	fig	CD	0
3B	3B	CD	0
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
of	of	IN	0
these	these	DT	0
p53	p53	NN	B-NP
constructs	constructs	NN	0
.	.	.	0
A	A	DT	0
p53-reporter	p53-reporter	JJ	B-NP
construct	construct	NN	0
,	,	,	0
p50-2	p50-2	NNP	B-NP
,	,	,	0
which	which	WDT	0
specifically	specifically	RB	0
responds	responds	VBZ	0
to	to	TO	0
wtp53	wtp53	CD	B-NP
by	by	IN	0
luciferase	luciferase	JJ	B-NP
gene	gene	NN	I-NP
increasing	increasing	VBG	I-NP
transcription	transcription	NN	I-NP
,	,	,	0
was	was	VBD	0
used	used	VBN	0
[	[	-LRB-	0
described	described	VBN	0
in	in	IN	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
fig	fig	CD	0
3B	3B	CD	0
,	,	,	0
saos-2	saos-2	NN	B-NP
cell	cell	NN	I-NP
transiently	transiently	FW	0
expressing	expressing	VBG	B-NP
vector	vector	NN	I-NP
(	(	-LRB-	0
Con	Con	NNP	0
)	)	-RRB-	0
,	,	,	0
showed	showed	VBD	0
minimal	minimal	JJ	0
p53-reporter	p53-reporter	JJ	B-NP
activation	activation	NN	I-NP
construct	construct	NN	0
.	.	.	0
Cells	Cells	NNS	0
expressing	expressing	VBG	B-NP
wtp53	wtp53	NNP	I-NP
showed	showed	VBD	0
significant	significant	JJ	0
activation	activation	NN	B-NP
,	,	,	0
as	as	RB	0
did	did	VBD	0
cells	cells	NNS	0
expressing	expressing	VBG	0
both	both	PDT	0
the	the	DT	0
S33A	S33A	NNP	0
and	and	CC	0
S37A	S37A	CD	0
mutations	mutations	NNS	0
.	.	.	0
Both	Both	PDT	0
the	the	DT	0
S33A	S33A	NNP	0
and	and	CC	0
S37A	S37A	CD	0
mutations	mutations	NNS	0
displayed	displayed	VBD	0
slightly	slightly	RB	0
higher	higher	RBR	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
basal	basal	JJ	I-NP
level	level	JJ	I-NP
than	than	IN	0
the	the	DT	0
wtp53	wtp53	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
serine	serine	NN	B-NP
33	33	CD	0
and	and	CC	0
37	37	CD	0
are	are	VBP	0
located	located	VBN	0
within	within	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
n-terminal	n-terminal	NN	I-NP
transcriptional	transcriptional	JJ	I-NP
activation	activation	JJ	I-NP
domain	domain	NN	I-NP
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
GSK3β	GSK3β	NNP	B-NP
regulates	regulates	VBZ	0
p53	p53	NN	0
's	's	POS	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
a	a	DT	0
wild	wild	JJ	0
type	type	NN	B-NP
GSK3β	GSK3β	CD	I-NP
expression	expression	NN	I-NP
vector	vector	NN	I-NP
was	was	VBD	0
cotransfected	cotransfected	VBN	0
with	with	IN	0
either	either	DT	0
wtp53	wtp53	NNP	B-NP
or	or	CC	0
p53	p53	NN	B-NP
with	with	IN	0
mutations	mutations	NNS	0
in	in	IN	0
serine	serine	NN	B-NP
33	33	CD	0
or	or	CC	0
37	37	CD	0
.	.	.	0
The	The	DT	0
gsk3β	gsk3β	NN	B-NP
ability	ability	NN	I-NP
to	to	TO	0
activate	activate	VB	0
each	each	DT	0
construct	construct	NN	0
was	was	VBD	0
calculated	calculated	VBN	0
by	by	IN	0
expressing	expressing	VBG	0
the	the	DT	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
GSK3β	GSK3β	CD	B-NP
as	as	IN	0
a	a	DT	0
percentage	percentage	NN	0
of	of	IN	0
that	that	WDT	0
observed	observed	VBD	0
in	in	IN	0
the	the	DT	0
gsk3β	gsk3β	NN	B-NP
absence	absence	NN	I-NP
.	.	.	0
On	On	IN	0
this	this	DT	0
scale	scale	NN	0
,	,	,	0
no	no	DT	0
activation	activation	NN	B-NP
by	by	IN	0
gsk3β	gsk3β	NN	B-NP
yield	yield	NN	I-NP
a	a	DT	0
zero	zero	CD	0
percent	percent	NN	0
increase	increase	NN	0
in	in	IN	0
p53	p53	NN	B-NP
transcriptional	transcriptional	VBZ	0
relative	relative	JJ	0
to	to	TO	0
p53	p53	NN	B-NP
alone	alone	RB	0
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
alone	alone	RB	0
(	(	-LRB-	0
fig	fig	FW	0
3C	3C	FW	0
,	,	,	0
Con	Con	NNP	0
)	)	-RRB-	0
did	did	VBD	0
not	not	RB	0
significantly	significantly	RB	0
increase	increase	VB	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
the	the	DT	0
luciferase	luciferase	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
.	.	.	0
When	When	WRB	0
GSK3β	GSK3β	NNP	B-NP
was	was	VBD	0
cotransfected	cotransfected	VBN	0
with	with	IN	0
wtp53	wtp53	NNP	B-NP
,	,	,	0
p53-dependent	p53-dependent	CD	B-NP
activity	activity	NN	I-NP
from	from	IN	0
the	the	DT	0
luciferase	luciferase	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	NNS	0
was	was	VBD	0
increased	increased	VBN	0
by	by	IN	0
160	160	CD	0
%	%	NN	0
compared	compared	VBN	0
to	to	TO	0
wtp53	wtp53	CD	B-NP
alone	alone	RB	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
this	this	DT	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
activation	activation	NN	I-NP
required	required	VBD	0
the	the	DT	0
GSK3β	GSK3β	JJ	B-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
at	at	IN	0
serine	serine	CD	B-NP
33	33	CD	0
,	,	,	0
wtp53	wtp53	NNP	B-NP
with	with	IN	0
serine	serine	VBG	0
to	to	TO	0
alanine	alanine	VB	0
mutations	mutations	VBN	0
at	at	IN	0
either	either	DT	0
positions	positions	NNS	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
were	were	VBD	0
cotransfected	cotransfected	VBN	0
with	with	IN	0
GSK3β	GSK3β	CD	B-NP
.	.	.	0
Mutation	Mutation	NN	0
of	of	IN	0
either	either	DT	0
serine	serine	JJ	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
significantly	significantly	RB	0
reduced	reduced	VBN	0
the	the	DT	0
gsk3β	gsk3β	NN	B-NP
ability	ability	NN	I-NP
to	to	TO	0
upregulate	upregulate	VB	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
.	.	.	0
This	This	DT	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
phosphorylation	phosphorylation	JJ	B-NP
data	data	NN	I-NP
in	in	IN	0
fig	fig	CD	0
1and	1and	CD	0
2	2	CD	0
,	,	,	0
which	which	WDT	0
indicated	indicated	VBD	0
that	that	IN	0
serine	serine	CD	B-NP
37	37	CD	0
phosphorylation	phosphorylation	NN	B-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
subsequent	subsequent	JJ	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
33	33	CD	0
by	by	IN	0
GSK3β	GSK3β	CD	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggests	suggests	VBZ	0
that	that	IN	0
GSK3β	GSK3β	NNP	B-NP
may	may	MD	0
be	be	VB	0
a	a	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
physiological	physiological	JJ	I-NP
regulator	regulator	NN	I-NP
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
constitutively	constitutively	JJ	0
active	active	JJ	0
in	in	IN	0
resting	resting	JJ	0
cells	cells	NNS	0
,	,	,	0
and	and	CC	0
is	is	VBZ	0
inactivated	inactivated	VBN	0
by	by	IN	0
protein	protein	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
b	b	NN	I-NP
through	through	IN	0
the	the	DT	0
growth	growth	NN	0
factor	factor	NN	0
dependent	dependent	FW	0
p110-PI	p110-PI	FW	0
3-kinase	3-kinase	FW	0
pathway	pathway	FW	0
[	[	-LRB-	0
25	25	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
GSK3β	GSK3β	CD	B-NP
in	in	IN	0
growing	growing	VBG	0
cells	cells	NNS	0
is	is	VBZ	0
less	less	JJR	0
than	than	IN	0
that	that	DT	0
in	in	IN	0
cells	cells	NNS	0
arrested	arrested	VBN	0
in	in	IN	0
Go.	Go.	CD	0
p53	p53	NN	B-NP
can	can	MD	0
be	be	VB	0
activated	activated	VBN	0
by	by	IN	0
several	several	JJ	0
distinct	distinct	JJ	0
pathways	pathways	NN	0
,	,	,	0
including	including	VBG	B-NP
DNA	DNA	NN	I-NP
damage	damage	NN	I-NP
.	.	.	0
If	If	IN	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
,	,	,	0
then	then	RB	0
GSK3β	GSK3β	RB	0
is	is	VBZ	0
predicted	predicted	VBN	0
to	to	TO	0
be	be	VB	0
upregulated	upregulated	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
.	.	.	0
In	In	IN	0
fig	fig	CD	0
4	4	CD	0
,	,	,	0
GSK3β	GSK3β	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
was	was	VBD	0
monitored	monitored	VBN	0
by	by	IN	0
immunoprecipitating	immunoprecipitating	JJ	B-NP
GSK3β	GSK3β	NN	I-NP
and	and	CC	0
then	then	RB	0
measuring	measuring	VBG	0
the	the	DT	0
immunoprecipitated	immunoprecipitated	JJ	B-NP
protein	protein	NN	I-NP
ability	ability	NN	I-NP
to	to	TO	0
phosphorylate	phosphorylate	VB	0
a	a	DT	0
specific	specific	JJ	0
GSK3β	GSK3β	NN	B-NP
peptide	peptide	NN	I-NP
substrate	substrate	NN	I-NP
.	.	.	0
In	In	IN	0
fig	fig	CD	0
4	4	CD	0
,	,	,	0
the	the	DT	0
omission	omission	NN	0
of	of	IN	0
either	either	RB	0
the	the	DT	0
peptide	peptide	NN	B-NP
or	or	CC	0
the	the	DT	0
GSK3β	GSK3β	JJ	B-NP
antibody	antibody	NN	I-NP
from	from	IN	0
the	the	DT	0
assay	assay	NN	B-NP
resulted	resulted	VBD	0
in	in	IN	0
minimal	minimal	JJ	0
substrate	substrate	JJ	B-NP
peptide	peptide	NNS	I-NP
phosphorylation	phosphorylation	NN	I-NP
(	(	-LRB-	0
fig	fig	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
both	both	DT	0
GSK3β	GSK3β	JJ	B-NP
antibody	antibody	NN	I-NP
and	and	CC	0
substrate	substrate	JJ	B-NP
peptide	peptide	NN	I-NP
were	were	VBD	0
employed	employed	VBN	0
,	,	,	0
high	high	JJ	0
levels	levels	NNS	0
of	of	IN	0
GSK3β-dependent	GSK3β-dependent	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
were	were	VBD	0
detected	detected	VBN	0
.	.	.	0
When	When	WRB	0
cells	cells	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
for	for	IN	0
24	24	CD	0
h	h	NN	0
in	in	IN	0
low	low	JJ	0
serum	serum	NN	B-NP
(	(	-LRB-	0
0.5	0.5	CD	0
%	%	NN	0
)	)	-RRB-	0
to	to	TO	0
induce	induce	VB	0
growth	growth	NN	B-NP
arrest	arrest	NN	I-NP
in	in	IN	0
Go	Go	NNP	0
,	,	,	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
GSK3β	GSK3β	CD	B-NP
activity	activity	NN	I-NP
were	were	VBD	0
increased	increased	VBN	0
compared	compared	VBN	0
to	to	TO	0
asynchronously	asynchronously	VB	0
growing	growing	VBG	0
cells	cells	NNS	0
(	(	-LRB-	0
fig	fig	CD	0
4	4	CD	0
,	,	,	0
Go	Go	NNP	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
asynchronously	asynchronously	NNS	0
growing	growing	VBG	0
cells	cells	NNS	0
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
5Gy	5Gy	CD	B-NP
or	or	CC	0
10Gy	10Gy	CD	0
of	of	IN	0
Ionizing	Ionizing	NNP	B-NP
Radiation	Radiation	NNP	I-NP
to	to	TO	0
cause	cause	VB	0
DNA	DNA	NN	B-NP
damage	damage	NN	I-NP
,	,	,	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
GSK3β	GSK3β	CD	B-NP
activity	activity	NN	I-NP
were	were	VBD	0
reduced	reduced	VBN	0
.	.	.	0
similar	similar	JJ	B-NP
result	result	NN	I-NP
were	were	VBD	0
seen	seen	VBN	0
using	using	VBG	0
p53-GST	p53-GST	NN	B-NP
as	as	IN	0
the	the	DT	0
substrate	substrate	NN	0
for	for	IN	0
GSK3β	GSK3β	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
in	in	IN	0
the	the	DT	0
kinase	kinase	JJ	B-NP
assay	assay	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
implies	implies	NN	0
that	that	IN	0
the	the	DT	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
would	would	MD	0
be	be	VB	0
decreased	decreased	VBN	0
in	in	IN	0
cells	cells	NNS	0
exposed	exposed	VBN	0
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
,	,	,	0
but	but	CC	0
elevated	elevated	VBD	0
in	in	IN	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
arrested	arrested	VBN	0
in	in	IN	0
Go	Go	NNP	0
.	.	.	0
Discussion	Discussion	NN	0
Several	Several	JJ	0
p53	p53	NN	B-NP
kinas	kinas	NNP	I-NP
were	were	VBD	0
examined	examined	VBN	0
for	for	IN	0
their	their	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
create	create	VB	0
in	in	IN	0
vitro	vitro	CD	B-NP
gsk3	gsk3	NN	I-NP
phosphorylation	phosphorylation	CD	I-NP
site	site	NN	I-NP
on	on	IN	0
p53	p53	NN	B-NP
.	.	.	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
created	created	VBD	0
a	a	DT	0
gsk3β	gsk3β	NN	B-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
for	for	IN	0
GSK3α	GSK3α	CD	B-NP
.	.	.	0
GSK3α	GSK3α	NNP	B-NP
and	and	CC	0
GSK3β	GSK3β	RB	0
have	have	VB	0
98	98	CD	0
%	%	NN	0
homology	homology	NN	B-NP
within	within	IN	0
the	the	DT	0
kinase	kinase	JJ	B-NP
domain	domain	NN	I-NP
,	,	,	0
although	although	IN	0
regions	regions	NNS	0
N-	N-	JJ	0
and	and	CC	0
C-terminal	C-terminal	JJ	B-NP
to	to	TO	0
this	this	DT	0
are	are	VBP	0
less	less	RBR	0
well	well	RB	0
conserved	conserved	JJ	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
GSK3α	GSK3α	NNP	B-NP
and	and	CC	0
GSK3β	GSK3β	NNP	B-NP
have	have	VBP	0
similar	similar	JJ	0
substrate	substrate	JJ	B-NP
specificity	specificity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
and	and	CC	0
are	are	VBP	0
regulated	regulated	VBN	0
in	in	IN	0
parallel	parallel	NN	B-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
[	[	-LRB-	0
24	24	CD	0
,	,	,	0
27	27	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
disruption	disruption	NN	0
of	of	IN	0
GSK3β	GSK3β	CD	B-NP
in	in	IN	0
mice	mice	JJ	0
results	results	NNS	0
in	in	IN	0
embryonic	embryonic	JJ	B-NP
lethality	lethality	NN	I-NP
and	and	CC	0
impaired	impaired	JJ	0
NFκ	NFκ	JJ	B-NP
B	B	NN	I-NP
function	function	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
GSK3α	GSK3α	CD	B-NP
cannot	cannot	JJ	0
substitute	substitute	NN	0
for	for	IN	0
GSK3β	GSK3β	CD	B-NP
in	in	IN	0
this	this	DT	0
model	model	NN	B-NP
system	system	NN	I-NP
.	.	.	0
GSK3α	GSK3α	NNP	B-NP
and	and	CC	0
GSK3β	GSK3β	NNP	B-NP
therefore	therefore	RB	0
have	have	VBP	0
overlapping	overlapping	VBG	0
cellular	cellular	JJ	B-NP
function	function	NN	I-NP
,	,	,	0
but	but	CC	0
each	each	DT	0
isoform	isoform	NN	B-NP
also	also	RB	0
regulates	regulates	VBZ	0
distinct	distinct	JJ	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
clearly	clearly	RB	0
show	show	VB	0
that	that	DT	0
p53	p53	NN	B-NP
phsophorylation	phsophorylation	NN	I-NP
is	is	VBZ	0
specific	specific	JJ	0
for	for	IN	0
GSK3β	GSK3β	CD	B-NP
.	.	.	0
The	The	DT	0
GSK3β	GSK3β	JJ	B-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
was	was	VBD	0
identified	identified	VBN	0
by	by	IN	0
mutagenesi	mutagenesi	NN	B-NP
as	as	IN	0
serine	serine	CD	B-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
,	,	,	0
and	and	CC	0
we	we	PRP	0
were	were	VBD	0
able	able	JJ	0
to	to	TO	0
show	show	VB	0
that	that	IN	0
this	this	DT	0
was	was	VBD	0
dependent	dependent	JJ	0
on	on	IN	0
prior	prior	JJ	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
37	37	CD	0
by	by	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
.	.	.	0
We	We	PRP	0
also	also	RB	0
examined	examined	VBN	0
if	if	IN	0
GSK3β	GSK3β	NNP	B-NP
regulates	regulates	VBZ	0
in	in	IN	0
vivo	vivo	JJ	B-NP
p53	p53	NN	I-NP
function	function	NN	I-NP
through	through	IN	0
a	a	DT	0
mechanism	mechanism	NN	0
involving	involving	VBG	B-NP
serine	serine	NN	I-NP
33	33	CD	0
and	and	CC	0
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
.	.	.	0
previous	previous	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
serine	serine	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
15	15	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
33	33	CD	0
and	and	CC	0
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
block	block	VB	0
the	the	DT	0
interaction	interaction	NN	0
of	of	IN	0
p53	p53	NN	B-NP
with	with	IN	0
mdm2	mdm2	NNP	B-NP
,	,	,	0
leading	leading	VBG	0
to	to	TO	0
stabilization	stabilization	VB	B-NP
and	and	CC	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
the	the	DT	0
cell	cell	NN	0
[	[	-LRB-	0
10	10	CD	0
,	,	,	0
11	11	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
,	,	,	0
15	15	CD	0
,	,	,	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
mdm2	mdm2	NN	B-NP
binding	binding	FW	0
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
the	the	DT	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	JJ	I-NP
status	status	NN	I-NP
20	20	CD	0
of	of	IN	0
p53	p53	NN	B-NP
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
,	,	,	0
although	although	IN	0
serine	serine	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
15	15	CD	0
,	,	,	0
33	33	CD	0
and	and	CC	0
37	37	CD	0
also	also	RB	0
play	play	VB	0
a	a	DT	0
role	role	NN	0
.	.	.	0
We	We	PRP	0
did	did	VBD	0
not	not	RB	0
detect	detect	VB	0
any	any	DT	0
significant	significant	JJ	0
difference	difference	NN	0
in	in	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
expression	expression	NN	0
of	of	IN	0
p53	p53	NN	B-NP
with	with	IN	0
single	single	JJ	0
mutations	mutations	NNS	0
in	in	IN	0
either	either	DT	0
serines	serines	JJ	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
when	when	WRB	0
compared	compared	VBN	0
to	to	TO	0
wtp53	wtp53	CD	B-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
single	single	JJ	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
in	in	IN	0
serine	serine	NN	B-NP
33	33	CD	0
or	or	CC	0
37	37	CD	0
do	do	VBP	0
not	not	RB	0
greatly	greatly	RB	0
alter	alter	VB	0
p53	p53	NN	B-NP
stability	stability	NN	I-NP
.	.	.	0
A	A	DT	0
p53	p53	NN	B-NP
key	key	JJ	I-NP
function	function	NN	I-NP
is	is	VBZ	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
activation	activation	NN	I-NP
of	of	IN	0
genes	genes	NNS	0
which	which	WDT	0
regulate	regulate	JJ	0
growth	growth	NN	B-NP
arrest	arrest	NN	I-NP
and	and	CC	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	CD	0
,	,	,	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
Individual	Individual	JJ	B-NP
mutation	mutation	NN	I-NP
of	of	IN	0
either	either	DT	0
serine	serine	JJ	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
slightly	slightly	RB	0
increased	increased	VBD	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
basal	basal	JJ	I-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
This	This	DT	0
is	is	VBZ	0
in	in	IN	0
keeping	keeping	VBG	0
with	with	IN	0
observation	observation	NN	B-NP
made	made	VBN	0
by	by	IN	0
other	other	JJ	0
groups	groups	NNS	0
,	,	,	0
who	who	WP	0
demonstrated	demonstrated	VBD	0
that	that	DT	0
single	single	JJ	0
or	or	CC	0
multiple	multiple	JJ	0
mutations	mutations	NNS	0
in	in	IN	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
site	site	NN	I-NP
has	has	VBZ	0
minimal	minimal	JJ	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
basal	basal	JJ	I-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
38	38	CD	0
,	,	,	0
39	39	CD	0
,	,	,	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
also	also	RB	0
determined	determined	VBN	0
if	if	IN	0
GSK3β	GSK3β	NNP	B-NP
could	could	MD	0
regulate	regulate	VB	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
constitutively	constitutively	JJ	0
active	active	JJ	0
in	in	IN	0
resting	resting	JJ	0
cells	cells	NNS	0
,	,	,	0
but	but	CC	0
exhibits	exhibits	VBZ	0
lower	lower	JJR	0
activity	activity	NN	0
in	in	IN	0
asynchronously	asynchronously	NNS	0
growing	growing	VBG	0
cells	cells	NNS	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
increase	increase	VB	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
GSK3β	GSK3β	NNP	B-NP
,	,	,	0
we	we	PRP	0
co-transfected	co-transfected	JJ	B-NP
GSK3β	GSK3β	NN	I-NP
with	with	IN	0
either	either	DT	0
wtp53	wtp53	NNP	B-NP
or	or	CC	0
p53	p53	NN	B-NP
bearing	bearing	NN	I-NP
serine	serine	NN	I-NP
to	to	TO	0
alanine	alanine	VB	0
mutations	mutations	VBN	0
at	at	IN	0
positions	positions	NNS	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
increased	increased	VBD	0
the	the	DT	0
wtp53	wtp53	NNP	B-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
of	of	IN	0
p53	p53	NN	B-NP
with	with	IN	0
mutations	mutations	NNS	0
in	in	IN	0
either	either	DT	0
serine	serine	JJ	0
33	33	CD	0
or	or	CC	0
37	37	CD	0
.	.	.	0
Therefore	Therefore	RB	0
both	both	DT	0
serine	serine	JJ	0
33	33	CD	0
and	and	CC	0
serine	serine	CD	B-NP
37	37	CD	0
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
GSK3β	GSK3β	CD	B-NP
to	to	TO	0
activate	activate	VB	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
regulates	regulates	VBZ	0
many	many	JJ	0
stress	stress	NN	0
activated	activated	VBN	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
nfκ	nfκ	NN	B-NP
b	b	NN	I-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
,	,	,	0
but	but	CC	0
inhibits	inhibits	JJ	0
heat	heat	NN	B-NP
shock	shock	NN	I-NP
factor-1	factor-1	NN	I-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
GSK3β	GSK3β	NNP	B-NP
may	may	MD	0
also	also	RB	0
be	be	VB	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
activation	activation	NN	I-NP
as	as	IN	0
well	well	RB	0
.	.	.	0
A	A	DT	0
key	key	JJ	B-NP
question	question	NN	I-NP
is	is	VBZ	0
whether	whether	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
or	or	CC	0
some	some	DT	0
other	other	JJ	0
kinase	kinase	NN	B-NP
phosphorylates	phosphorylates	VBD	0
serine	serine	CD	B-NP
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
is	is	VBZ	0
460	460	CD	0
kd	kd	CD	B-NP
DNA-activated	DNA-activated	JJ	I-NP
protein	protein	NN	I-NP
kinasa	kinasa	NN	I-NP
which	which	WDT	0
participates	participates	VBZ	0
in	in	IN	0
the	the	DT	0
cellular	cellular	JJ	B-NP
response	response	NN	I-NP
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
DNA	DNA	NNP	B-NP
strand-break	strand-break	JJ	I-NP
repair	repair	NN	I-NP
,	,	,	0
and	and	CC	0
can	can	MD	0
phosphorylate	phosphorylate	VB	0
serine	serine	NN	B-NP
15	15	CD	0
and	and	CC	0
serine	serine	CD	B-NP
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
Some	Some	DT	0
reports	reports	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
,	,	,	0
but	but	CC	0
recent	recent	JJ	0
genetic	genetic	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
shown	shown	VBN	0
clearly	clearly	RB	0
that	that	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
is	is	VBZ	0
not	not	RB	0
required	required	VBN	0
for	for	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
Ionizing	Ionizing	NNP	B-NP
Radiation	Radiation	NNP	I-NP
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
Whether	Whether	IN	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
other	other	JJ	0
stimuli	stimuli	NN	0
is	is	VBZ	0
not	not	RB	0
known	known	VBN	0
.	.	.	0
A	A	DT	0
more	more	RBR	0
likely	likely	JJ	0
candidate	candidate	NN	0
is	is	VBZ	0
the	the	DT	0
Atr	Atr	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
a	a	DT	0
kinase	kinase	NN	B-NP
related	related	VBN	0
to	to	TO	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
[	[	-LRB-	0
44	44	CD	0
]	]	-RRB-	0
,	,	,	0
which	which	WDT	0
can	can	MD	0
regulate	regulate	VB	0
the	the	DT	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
.	.	.	0
The	The	DT	0
present	present	JJ	0
data	data	NN	0
indicates	indicates	VBZ	0
that	that	DT	0
p53	p53	NN	B-NP
transcriptional	transcriptional	JJ	I-NP
activation	activation	NN	I-NP
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
requires	requires	VBZ	0
both	both	DT	0
serines	serines	JJ	0
33	33	CD	0
and	and	CC	0
37	37	CD	0
,	,	,	0
but	but	CC	0
it	it	PRP	0
does	does	VBZ	0
not	not	RB	0
allow	allow	VB	0
us	us	PRP	0
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
33	33	CD	0
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
serine	serine	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
37	37	CD	0
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
,	,	,	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
GSK3β	GSK3β	NNP	B-NP
directly	directly	RB	0
serine	serine	CD	B-NP
phosphorylate	phosphorylate	NN	I-NP
33	33	CD	0
independently	independently	NN	0
of	of	IN	0
serine	serine	CD	B-NP
37	37	CD	0
,	,	,	0
but	but	CC	0
that	that	IN	0
both	both	DT	0
residues	residues	NN	0
must	must	MD	0
be	be	VB	0
phosphorylated	phosphorylated	VBN	0
for	for	IN	0
transcriptional	transcriptional	JJ	B-NP
activation	activation	NN	I-NP
to	to	TO	0
occur	occur	VB	0
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
Future	Future	JJ	0
studies	studies	NNS	0
will	will	MD	0
address	address	VB	0
this	this	DT	0
issue.	issue.	JJ	0
p53	p53	NN	B-NP
is	is	VBZ	0
activated	activated	VBN	0
by	by	IN	0
multiple	multiple	JJ	0
pathways	pathways	NN	0
,	,	,	0
including	including	VBG	B-NP
DNA	DNA	NN	I-NP
damage	damage	NN	I-NP
and	and	CC	0
oncogene	oncogene	JJ	B-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
If	If	IN	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
,	,	,	0
GSK3β	GSK3β	CD	B-NP
activity	activity	NN	I-NP
should	should	MD	0
be	be	VB	0
regulated	regulated	VBN	0
by	by	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
when	when	WRB	0
cells	cells	NNS	0
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
Ionizing	Ionizing	NNP	B-NP
Radiation	Radiation	NNP	I-NP
,	,	,	0
GSK3β	GSK3β	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
was	was	VBD	0
inhibited	inhibited	VBN	0
rather	rather	RB	0
than	than	IN	0
enhanced	enhanced	JJ	0
,	,	,	0
implying	implying	VBG	0
p53	p53	NN	B-NP
decreased	decreased	VBN	I-NP
gsk3β-dependent	gsk3β-dependent	NN	I-NP
phosphorylation	phosphorylation	NN	I-NP
after	after	IN	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
.	.	.	0
Serine	Serine	NNP	B-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
is	is	VBZ	0
also	also	RB	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
other	other	JJ	0
kinas	kinas	NNP	B-NP
,	,	,	0
including	including	VBG	0
the	the	DT	0
CDK7-cyclin	CDK7-cyclin	NNP	B-NP
H	H	NNP	I-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
45	45	CD	0
]	]	-RRB-	0
and	and	CC	0
p38	p38	NNP	B-NP
MAPK	MAPK	NNP	I-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
p38	p38	NN	B-NP
MAPK	MAPK	NN	I-NP
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
genotoxic	genotoxic	JJ	B-NP
stress	stress	NN	I-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
may	may	MD	0
be	be	VB	0
responsible	responsible	JJ	0
for	for	IN	0
p53	p53	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
at	at	IN	0
serine	serine	CD	B-NP
33	33	CD	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
DNA	DNA	NNP	B-NP
damage	damage	NN	I-NP
.	.	.	0
p53	p53	NN	B-NP
gsk3β-dependent	gsk3β-dependent	NN	I-NP
phosphorylation	phosphorylation	NN	I-NP
at	at	IN	0
serine	serine	CD	B-NP
33	33	CD	0
may	may	MD	0
be	be	VB	0
part	part	NN	0
of	of	IN	0
other	other	JJ	0
p53-regulatory	p53-regulatory	CD	B-NP
pathway	pathway	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
oncogene	oncogene	JJ	B-NP
activation	activation	NN	I-NP
or	or	CC	0
apoptosi	apoptosi	NN	B-NP
,	,	,	0
which	which	WDT	0
are	are	VBP	0
not	not	RB	0
directly	directly	RB	0
activated	activated	VBN	0
by	by	IN	0
DNA-damage	DNA-damage	JJ	B-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
activation	activation	VBG	B-NP
of	of	IN	0
the	the	DT	0
p110-PI	p110-PI	NNP	0
3-kinase	3-kinase	NNP	0
/	/	NNP	0
PKB	PKB	NNP	0
pathway	pathway	NN	0
delivers	delivers	VBZ	0
an	an	DT	0
anti-apoptotic	anti-apoptotic	JJ	B-NP
signal	signal	NN	I-NP
to	to	TO	0
the	the	DT	0
cell	cell	NN	0
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
25	25	CD	0
,	,	,	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
Further	Further	RB	0
,	,	,	0
activation	activation	VBG	B-NP
of	of	IN	0
the	the	DT	0
p110-PI	p110-PI	NNP	0
3-kinase	3-kinase	NNP	0
/	/	NNP	0
PKB	PKB	NNP	0
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
both	both	DT	0
p53	p53	NN	B-NP
dependent	dependent	JJ	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
and	and	CC	0
p53	p53	NN	B-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
49	49	CD	0
,	,	,	0
50	50	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
protein	protein	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
b	b	NN	I-NP
has	has	VBZ	0
many	many	JJ	0
down	down	IN	0
stream	stream	NN	B-NP
target	target	NN	I-NP
which	which	WDT	0
may	may	MD	0
regulate	regulate	VB	0
these	these	DT	0
effects	effects	NNS	0
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
a	a	DT	0
protein	protein	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
b	b	NN	I-NP
key	key	JJ	I-NP
target	target	NN	I-NP
is	is	VBZ	0
GSK3β	GSK3β	NNP	B-NP
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
gsk3β	gsk3β	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
protein	protein	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
b	b	NN	I-NP
inhibits	inhibits	FW	0
GSK3β	GSK3β	NN	B-NP
kinase	kinase	NN	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
would	would	MD	0
be	be	VB	0
predicted	predicted	VBN	0
to	to	TO	0
block	block	VB	0
phosphorylation	phosphorylation	VBN	0
of	of	IN	0
serine	serine	CD	B-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
by	by	IN	0
GSK3β	GSK3β	NNP	B-NP
,	,	,	0
decreasing	decreasing	VBG	B-NP
p53	p53	NN	I-NP
transcriptional	transcriptional	NN	I-NP
activity	activity	NN	I-NP
and	and	CC	0
therefore	therefore	RB	0
reducing	reducing	VBG	0
the	the	DT	0
p53-regulated	p53-regulated	CD	B-NP
growth	growth	NN	I-NP
transcription	transcription	NN	I-NP
and	and	CC	0
pro-apoptotic	pro-apoptotic	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
gsk3β	gsk3β	NN	B-NP
potential	potential	JJ	I-NP
role	role	NN	I-NP
clarification	clarification	NN	I-NP
in	in	IN	0
regulating	regulating	VBG	B-NP
p53	p53	NN	I-NP
activation	activation	NN	I-NP
by	by	IN	0
non-dna	non-dna	NN	B-NP
damage	damage	NN	I-NP
pathway	pathway	NN	I-NP
will	will	MD	0
require	require	VB	0
additional	additional	JJ	0
study	study	NN	0
.	.	.	0
Conclusions	Conclusions	NNS	0
This	This	DT	0
study	study	NN	0
demonstrates	demonstrates	VBZ	0
that	that	IN	0
GSK3β	GSK3β	NNP	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
GSK3α	GSK3α	CD	B-NP
,	,	,	0
can	can	MD	0
directly	directly	RB	0
phosphorylate	phosphorylate	CD	B-NP
serine	serine	CD	I-NP
33	33	CD	0
of	of	IN	0
p53	p53	NN	B-NP
when	when	WRB	0
serine	serine	JJ	0
37	37	CD	0
of	of	IN	0
p53	p53	NN	B-NP
is	is	VBZ	0
already	already	RB	0
phosphorylated	phosphorylated	VBN	0
.	.	.	0
GSK3β	GSK3β	NNP	B-NP
can	can	MD	0
increase	increase	VB	0
p53	p53	NN	0
's	's	POS	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
and	and	CC	0
this	this	DT	0
activation	activation	NN	B-NP
requires	requires	VBZ	0
serine	serine	NN	B-NP
33	33	CD	0
and	and	CC	0
37	37	CD	0
of	of	IN	0
the	the	DT	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
Thus	Thus	RB	0
GSK3β	GSK3β	CD	B-NP
may	may	MD	0
phosphorylate	phosphorylate	VB	0
and	and	CC	0
activate	activate	JJ	0
p53	p53	NN	B-NP
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
However	However	RB	0
,	,	,	0
GSK3β	GSK3β	NNP	B-NP
is	is	VBZ	0
not	not	RB	0
part	part	NN	0
of	of	IN	0
the	the	DT	0
p53-DNA	p53-DNA	JJ	B-NP
damage	damage	NN	I-NP
response	response	NN	I-NP
pathway	pathway	NN	I-NP
.	.	.	0
Instead	Instead	RB	0
,	,	,	0
GSK3β	GSK3β	NNP	B-NP
may	may	MD	0
provide	provide	VB	0
the	the	DT	0
link	link	NN	0
between	between	IN	0
p53	p53	NN	B-NP
and	and	CC	0
p53	p53	NN	B-NP
activation	activation	NN	I-NP
non-dna	non-dna	NN	I-NP
damage	damage	NN	I-NP
mechanism	mechanism	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
oncogene	oncogene	JJ	B-NP
activation	activation	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
methods	methods	NNS	0
phosphorylation	phosphorylation	NN	B-NP
reaction	reaction	NN	I-NP
Wild	Wild	NNP	0
type	type	NN	B-NP
p53	p53	NN	I-NP
or	or	CC	0
p53	p53	NN	B-NP
bearing	bearing	NN	I-NP
mutation	mutation	NN	I-NP
in	in	IN	0
serine	serine	NN	B-NP
33	33	CD	0
or	or	CC	0
37	37	CD	0
were	were	VBD	0
subcloned	subcloned	VBN	0
into	into	IN	0
pGEX-2T	pGEX-2T	NNP	B-NP
GST	GST	NNP	I-NP
fusion	fusion	NN	I-NP
vector	vector	NN	I-NP
(	(	-LRB-	0
Pharmacia	Pharmacia	NNP	B-NP
,	,	,	0
neighbor	neighbor	NN	B-NP
joining	joining	VBG	I-NP
)	)	-RRB-	0
and	and	CC	0
p53-GST	p53-GST	CD	B-NP
purified	purified	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
p53-GST	p53-GST	NN	B-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
2	2	CD	0
μg	μg	NN	B-NP
;	;	:	0
measured	measured	VBN	0
using	using	VBG	0
Bio-Rad	Bio-Rad	JJ	B-NP
Protein	Protein	NNP	I-NP
assay	assay	VBD	0
Kit	Kit	NNP	0
,	,	,	0
Biorad	Biorad	NNP	B-NP
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
MAP	MAP	NNP	B-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
Erk2	Erk2	NNP	B-NP
,	,	,	0
10	10	CD	0
Units	Units	NNS	0
,	,	,	0
new	new	JJ	B-NP
england	england	NNP	I-NP
biolab	biolab	NN	I-NP
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
A	A	NNP	0
(	(	-LRB-	0
Catalytic	Catalytic	NNP	B-NP
sub-unit	sub-unit	NNP	I-NP
,	,	,	0
5	5	CD	0
Units	Units	NNS	0
,	,	,	0
Calbiochem	Calbiochem	NNP	B-NP
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
S6	S6	CD	B-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
0.2	0.2	CD	0
Units	Units	NNS	0
,	,	,	0
Upstate	Upstate	NNP	0
Biotechnology	Biotechnology	NNP	0
,	,	,	0
NY	NY	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
C	C	NNP	I-NP
(	(	-LRB-	0
O.1	O.1	NNP	0
munit	munit	NN	B-NP
,	,	,	0
Roche	Roche	NNP	0
molecular	molecular	JJ	B-NP
biochemical	biochemical	JJ	I-NP
,	,	,	0
IN	IN	IN	0
)	)	-RRB-	0
or	or	CC	0
dependent	dependent	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
(	(	-LRB-	0
20	20	CD	0
Units	Units	NNS	0
,	,	,	0
Promega	Promega	NNP	B-NP
Corp	Corp	NNP	0
,	,	,	0
Wl	Wl	NNP	B-NP
)	)	-RRB-	0
for	for	IN	0
5	5	CD	0
h	h	NN	0
at	at	IN	0
30°C	30°C	CD	0
in	in	IN	0
the	the	DT	0
following	following	JJ	0
buffers	buffers	NNS	0
(	(	-LRB-	0
40	40	CD	0
μl	μl	CD	B-NP
final	final	JJ	I-NP
volume	volume	NN	I-NP
)	)	-RRB-	0
.	.	.	0
MAP	MAP	NN	B-NP
kinasa	kinasa	NN	I-NP
and	and	CC	0
Protein	Protein	NNP	B-NP
Kinase	Kinase	NNP	I-NP
A	A	NNP	0
:	:	:	0
20	20	CD	0
ph	ph	NN	B-NP
mm	mm	NN	I-NP
hepe	hepe	NN	I-NP
7.2	7.2	CD	0
/	/	CD	0
10	10	CD	0
mM	mM	JJ	B-NP
Na-Acetate	Na-Acetate	JJ	I-NP
/	/	CD	0
30	30	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
/	/	CD	0
0.2	0.2	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
/	/	NNP	0
I0	I0	NNP	B-NP
μM	μM	NNP	I-NP
ATP	ATP	NNP	I-NP
.	.	.	0
S6	S6	NNP	B-NP
Kinase	Kinase	NNP	I-NP
:	:	:	0
20	20	CD	0
mM	mM	JJ	0
MOPS	MOPS	NNP	0
pH	pH	NNP	B-NP
7.2	7.2	CD	0
/	/	CD	0
30	30	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
/	/	CD	0
5	5	CD	0
mM	mM	JJ	B-NP
EGTA	EGTA	NNP	I-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
/	/	NNP	0
I0	I0	NNP	B-NP
μM	μM	NNP	I-NP
ATP	ATP	NNP	I-NP
.	.	.	0
DNA-PK	DNA-PK	NNP	0
:	:	:	0
25	25	CD	0
mM	mM	JJ	0
Hepes	Hepes	NNP	0
pH7.5	pH7.5	CD	0
/	/	CD	0
150	150	CD	0
mM	mM	JJ	0
KCI	KCI	NNP	0
/	/	CD	0
10	10	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
/	/	CD	0
20	20	CD	0
%	%	NN	0
Glycerol	Glycerol	NNP	0
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
NP40	NP40	CD	0
/	/	CD	0
20	20	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	0
2	2	CD	0
/	/	CD	0
1	1	CD	0
mM	mM	JJ	0
DTT	DTT	NNP	0
/	/	CD	0
250	250	CD	0
ng	ng	JJ	0
DNA	DNA	NN	0
/	/	CD	0
4.2	4.2	CD	0
mM	mM	JJ	0
spermidine	spermidine	NN	0
/	/	CD	0
10	10	CD	0
μM	μM	JJ	0
ATP	ATP	NNP	0
.	.	.	0
PKC	PKC	NNP	0
:	:	:	0
20	20	CD	0
mM	mM	JJ	0
Hepes	Hepes	NNP	0
pH	pH	NNP	0
7.4	7.4	CD	0
/	/	CD	0
20	20	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
/	/	CD	0
0.2	0.2	CD	0
mM	mM	JJ	0
EGTA	EGTA	NNP	0
/	/	CD	0
1	1	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	0
2	2	CD	0
/	/	CD	0
1.5	1.5	CD	0
μg	μg	CD	0
phosphatidylserine	phosphatidylserine	NNS	0
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
at	at	IN	0
65°C	65°C	CD	0
for	for	IN	0
20	20	CD	0
min	min	NN	0
to	to	TO	0
inactivate	inactivate	VB	0
kinases	kinases	NNS	0
,	,	,	0
and	and	CC	0
25	25	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
reaction	reaction	NN	0
incubated	incubated	NN	0
for	for	IN	0
30	30	CD	0
min	min	NN	0
with	with	IN	0
GSK3α	GSK3α	NNP	0
or	or	CC	0
GSK3β	GSK3β	CD	0
in	in	IN	0
GSK3	GSK3	FW	0
kinase	kinase	FW	0
buffer	buffer	FW	0
(	(	-LRB-	0
KGB	KGB	NNP	0
Buffer	Buffer	NNP	0
:	:	:	0
8	8	CD	0
mM	mM	JJ	0
MOPS	MOPS	NNP	0
,	,	,	0
pH7.2	pH7.2	CD	0
/	/	CD	0
10	10	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
/	/	CD	0
0.2	0.2	CD	0
mM	mM	JJ	0
EDTA	EDTA	NNP	0
/	/	CD	0
5	5	CD	0
μM	μM	JJ	0
ATP	ATP	NNP	0
/	/	CD	0
10	10	CD	0
μCi	μCi	JJ	0
32P-ATP	32P-ATP	CD	0
)	)	-RRB-	0
in	in	IN	0
a	a	DT	0
final	final	JJ	0
volume	volume	NN	0
of	of	IN	0
40	40	CD	0
μl	μl	NNS	0
.	.	.	0
Reactions	Reactions	NNS	0
were	were	VBD	0
terminated	terminated	VBN	0
by	by	IN	0
the	the	DT	0
addition	addition	NN	0
of	of	IN	0
SDS	SDS	NNP	0
sample	sample	NN	0
buffer	buffer	NN	0
and	and	CC	0
p53-GST	p53-GST	NNP	0
phosphorylation	phosphorylation	VBD	0
detected	detected	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	JJ	0
and	and	CC	0
auotradiography	auotradiography	NN	0
.	.	.	0
Equal	Equal	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
p53-GST	p53-GST	NNP	0
(	(	-LRB-	0
0.25	0.25	CD	0
μg	μg	CD	0
)	)	-RRB-	0
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	JJ	0
and	and	CC	0
equal	equal	JJ	0
loading	loading	NN	0
confirmed	confirmed	VBD	0
by	by	IN	0
coomassie	coomassie	JJ	0
blue	blue	JJ	0
staining	staining	NN	0
of	of	IN	0
the	the	DT	0
SDS-PAG	SDS-PAG	JJ	0
.	.	.	0
gsk3	gsk3	NN	B-NP
immunokinase	immunokinase	NN	I-NP
assay	assay	NN	I-NP
saos-2	saos-2	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
6	6	CD	0
)	)	-RRB-	0
were	were	VBD	0
lyzed	lyzed	VBN	0
in	in	IN	0
0.5	0.5	CD	0
ml	ml	NN	0
of	of	IN	0
GLB	GLB	NNP	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris	Tris	NNP	I-NP
pH7.5	pH7.5	CD	I-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
EGTA	EGTA	NNP	I-NP
/	/	CD	0
0.5	0.5	CD	0
%	%	NN	0
NP40	NP40	CD	B-NP
/	/	CD	0
0.5	0.5	CD	0
M	M	NNP	0
NaCI	NaCI	NNP	B-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
/	/	CD	0
1	1	CD	0
mM	mM	JJ	B-NP
PMSF	PMSF	NNP	I-NP
/	/	CD	I-NP
leupeptin	leupeptin	CD	I-NP
/	/	CD	I-NP
aprotinin	aprotinin	CD	I-NP
/	/	CD	0
600	600	CD	0
μM	μM	JJ	0
Na	Na	NNP	0
3	3	CD	0
VO	VO	CD	B-NP
4	4	CD	0
/	/	CD	0
50	50	CD	0
mM	mM	JJ	B-NP
NaF	NaF	NN	I-NP
)	)	-RRB-	0
.	.	.	0
Extracts	Extracts	NNP	0
were	were	VBD	0
cleared	cleared	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
and	and	CC	0
incubated	incubated	NN	0
with	with	IN	0
GSK3	GSK3	CD	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
1	1	CD	0
μg	μg	NN	B-NP
;	;	:	0
Upstate	Upstate	NNP	B-NP
Biotech	Biotech	NNP	I-NP
,	,	,	0
NY	NY	NNP	B-NP
)	)	-RRB-	0
prebound	prebound	NN	B-NP
to	to	TO	0
Sepharose	Sepharose	NNP	B-NP
A	A	NNP	I-NP
/	/	NNP	I-NP
G	G	NNP	I-NP
agarose	agarose	VBD	0
beads	beads	VBN	0
for	for	IN	0
2	2	CD	0
h	h	NNS	0
.	.	.	0
The	The	DT	0
beads	beads	NN	0
were	were	VBD	0
washed	washed	VBN	0
in	in	IN	0
4	4	CD	0
×	×	CD	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
GLB	GLB	NNP	B-NP
buffer	buffer	NN	I-NP
and	and	CC	0
then	then	RB	0
in	in	IN	0
2	2	CD	0
×	×	CD	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
KGB	KGB	NNP	B-NP
buffer	buffer	NN	I-NP
.	.	.	0
kinase	kinase	NN	B-NP
reaction	reaction	NN	I-NP
contained	contained	VBD	0
5	5	CD	0
μM	μM	JJ	B-NP
ATP	ATP	NNP	I-NP
/	/	CD	0
15	15	CD	0
μCi	μCi	JJ	0
32P-ATP	32P-ATP	CD	0
/	/	CD	0
0.5	0.5	CD	0
μg	μg	CD	B-NP
PhosphoCREB	PhosphoCREB	JJ	I-NP
peptide	peptide	NN	I-NP
in	in	IN	0
30	30	CD	0
kgb	kgb	NN	B-NP
μl	μl	NN	I-NP
.	.	.	0
After	After	IN	0
incubate	incubate	NN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
at	at	IN	0
room	room	NN	B-NP
temperature	temperature	NN	I-NP
,	,	,	0
the	the	DT	0
beads	beads	NN	0
were	were	VBD	0
collected	collected	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
and	and	CC	0
20	20	CD	0
reaction	reaction	NN	B-NP
mix	mix	NN	I-NP
μl	μl	NN	I-NP
spotted	spotted	VBD	0
onto	onto	IN	0
circles	circles	NNS	0
of	of	IN	0
P81	P81	CD	B-NP
paper	paper	NN	I-NP
(	(	-LRB-	0
Whatman	Whatman	NNP	B-NP
,	,	,	0
USA	USA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
P81	P81	JJ	B-NP
paper	paper	NN	I-NP
was	was	VBD	0
washed	washed	VBN	0
in	in	IN	0
4	4	CD	0
×	×	CD	0
10	10	CD	0
ml	ml	CD	0
changes	changes	NNS	0
of	of	IN	0
100	100	CD	0
mM	mM	JJ	0
phosphoric	phosphoric	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
dried	dried	VBN	0
and	and	CC	0
counted	counted	VBN	0
.	.	.	0
PhosphoCREB	PhosphoCREB	JJ	B-NP
peptida	peptida	NN	I-NP
(	(	-LRB-	I-NP
sequence	sequence	NN	I-NP
KRREILSRRPS	KRREILSRRPS	NN	I-NP
(	(	-LRB-	I-NP
P	P	NN	I-NP
)	)	-RRB-	I-NP
YR	YR	NNP	I-NP
)	)	-RRB-	0
was	was	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
new	new	JJ	B-NP
england	england	NNP	I-NP
biolab	biolab	NN	I-NP
,	,	,	0
MA	MA	NNP	0
.	.	.	0
mutagenesi	mutagenesi	NN	B-NP
was	was	VBD	0
carried	carried	VBN	0
out	out	RP	0
using	using	VBG	0
the	the	DT	0
Altered	Altered	NNP	0
Sites	Sites	NNP	0
Mutagenesis	Mutagenesis	NNP	B-NP
System	System	NNP	I-NP
(	(	-LRB-	0
Promega	Promega	NNP	B-NP
,	,	,	0
Wl	Wl	NNP	B-NP
)	)	-RRB-	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
by	by	IN	0
us	us	PRP	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
Human	Human	JJ	B-NP
wild	wild	JJ	I-NP
type	type	NN	I-NP
p53	p53	NN	I-NP
or	or	CC	0
p53	p53	NN	B-NP
bearing	bearing	NN	I-NP
mutation	mutation	NN	I-NP
in	in	IN	0
serine	serine	NN	B-NP
33	33	CD	0
or	or	CC	0
37	37	CD	0
were	were	VBD	0
inserted	inserted	VBN	0
into	into	IN	0
the	the	DT	0
BamH1	BamH1	JJ	B-NP
site	site	NN	I-NP
of	of	IN	0
the	the	DT	0
pcDNA3.1	pcDNA3.1	JJ	0
expression	expression	NN	B-NP
vector	vector	NN	I-NP
(	(	-LRB-	0
Invitrogen	Invitrogen	NNP	B-NP
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
luciferase	luciferase	NN	B-NP
reporter	reporter	NN	I-NP
assay	assay	NN	I-NP
were	were	VBD	0
carried	carried	VBN	0
out	out	RP	0
in	in	IN	0
the	the	DT	0
p53	p53	NN	B-NP
null	null	NN	0
cell	cell	NN	B-NP
line	line	NN	I-NP
SAOS-2	SAOS-2	VBZ	I-NP
using	using	VBG	0
the	the	DT	0
p53	p53	NN	B-NP
specific	specific	JJ	0
luciferase	luciferase	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	VBD	0
p50-Luc	p50-Luc	CD	B-NP
,	,	,	0
and	and	CC	0
pCMV-β-galatosidase	pCMV-β-galatosidase	JJ	B-NP
to	to	TO	0
control	control	VB	0
for	for	IN	0
transfection	transfection	JJ	B-NP
efficiency	efficiency	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
transfected	transfected	VBN	0
using	using	VBG	0
Lipofectin	Lipofectin	NNP	B-NP
(	(	-LRB-	0
Gibco-BRL	Gibco-BRL	NNP	B-NP
)	)	-RRB-	0
containing	containing	VBG	B-NP
p50-Luc	p50-Luc	NNP	I-NP
(	(	-LRB-	0
1	1	CD	0
μg	μg	CD	B-NP
)	)	-RRB-	0
,	,	,	0
pCMV-Gal	pCMV-Gal	NNP	B-NP
(	(	-LRB-	0
1	1	CD	0
μg	μg	CD	B-NP
)	)	-RRB-	0
and	and	CC	0
pcDNAp53	pcDNAp53	NNP	B-NP
(	(	-LRB-	0
50	50	CD	0
ng	ng	CD	B-NP
)	)	-RRB-	0
in	in	IN	0
a	a	DT	0
final	final	JJ	B-NP
volume	volume	NN	I-NP
of	of	IN	0
400	400	CD	0
μl	μl	NN	B-NP
as	as	RB	0
described	described	VBN	0
in	in	IN	0
the	the	DT	0
manufacturer	manufacturer	NN	B-NP
protocol	protocol	NN	I-NP
.	.	.	0
